IBDEI07Q ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3046,2)
 ;;=^5002379
 ;;^UTILITY(U,$J,358.3,3047,0)
 ;;=D72.9^^28^246^37
 ;;^UTILITY(U,$J,358.3,3047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3047,1,3,0)
 ;;=3^White Blood Cells Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,3047,1,4,0)
 ;;=4^D72.9
 ;;^UTILITY(U,$J,358.3,3047,2)
 ;;=^5002381
 ;;^UTILITY(U,$J,358.3,3048,0)
 ;;=L02.91^^28^247^1
 ;;^UTILITY(U,$J,358.3,3048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3048,1,3,0)
 ;;=3^Abcess,Cutaneous,Unspec
 ;;^UTILITY(U,$J,358.3,3048,1,4,0)
 ;;=4^L02.91
 ;;^UTILITY(U,$J,358.3,3048,2)
 ;;=^5009016
 ;;^UTILITY(U,$J,358.3,3049,0)
 ;;=L11.9^^28^247^2
 ;;^UTILITY(U,$J,358.3,3049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3049,1,3,0)
 ;;=3^Acantholytic Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,3049,1,4,0)
 ;;=4^L11.9
 ;;^UTILITY(U,$J,358.3,3049,2)
 ;;=^5009094
 ;;^UTILITY(U,$J,358.3,3050,0)
 ;;=L83.^^28^247^3
 ;;^UTILITY(U,$J,358.3,3050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3050,1,3,0)
 ;;=3^Acanthosis Nigricans
 ;;^UTILITY(U,$J,358.3,3050,1,4,0)
 ;;=4^L83.
 ;;^UTILITY(U,$J,358.3,3050,2)
 ;;=^1451
 ;;^UTILITY(U,$J,358.3,3051,0)
 ;;=L70.9^^28^247^4
 ;;^UTILITY(U,$J,358.3,3051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3051,1,3,0)
 ;;=3^Acne,Unspec
 ;;^UTILITY(U,$J,358.3,3051,1,4,0)
 ;;=4^L70.9
 ;;^UTILITY(U,$J,358.3,3051,2)
 ;;=^5009273
 ;;^UTILITY(U,$J,358.3,3052,0)
 ;;=L57.0^^28^247^5
 ;;^UTILITY(U,$J,358.3,3052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3052,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,3052,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,3052,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,3053,0)
 ;;=N65.0^^28^247^16
 ;;^UTILITY(U,$J,358.3,3053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3053,1,3,0)
 ;;=3^Breast,Reconstructed Deformity
 ;;^UTILITY(U,$J,358.3,3053,1,4,0)
 ;;=4^N65.0
 ;;^UTILITY(U,$J,358.3,3053,2)
 ;;=^5015800
 ;;^UTILITY(U,$J,358.3,3054,0)
 ;;=N64.9^^28^247^9
 ;;^UTILITY(U,$J,358.3,3054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3054,1,3,0)
 ;;=3^Breast Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,3054,1,4,0)
 ;;=4^N64.9
 ;;^UTILITY(U,$J,358.3,3054,2)
 ;;=^5015799
 ;;^UTILITY(U,$J,358.3,3055,0)
 ;;=N65.1^^28^247^15
 ;;^UTILITY(U,$J,358.3,3055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3055,1,3,0)
 ;;=3^Breast Reconstructed Disproportion
 ;;^UTILITY(U,$J,358.3,3055,1,4,0)
 ;;=4^N65.1
 ;;^UTILITY(U,$J,358.3,3055,2)
 ;;=^5015801
 ;;^UTILITY(U,$J,358.3,3056,0)
 ;;=N60.92^^28^247^10
 ;;^UTILITY(U,$J,358.3,3056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3056,1,3,0)
 ;;=3^Breast Dysplasia,Benign Mammary,Left
 ;;^UTILITY(U,$J,358.3,3056,1,4,0)
 ;;=4^N60.92
 ;;^UTILITY(U,$J,358.3,3056,2)
 ;;=^5134091
 ;;^UTILITY(U,$J,358.3,3057,0)
 ;;=N60.91^^28^247^11
 ;;^UTILITY(U,$J,358.3,3057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3057,1,3,0)
 ;;=3^Breast Dysplasia,Benign Mammary,Right
 ;;^UTILITY(U,$J,358.3,3057,1,4,0)
 ;;=4^N60.91
 ;;^UTILITY(U,$J,358.3,3057,2)
 ;;=^5015788
 ;;^UTILITY(U,$J,358.3,3058,0)
 ;;=N62.^^28^247^12
 ;;^UTILITY(U,$J,358.3,3058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3058,1,3,0)
 ;;=3^Breast Hypertrophy
 ;;^UTILITY(U,$J,358.3,3058,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,3058,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,3059,0)
 ;;=N61.^^28^247^13
 ;;^UTILITY(U,$J,358.3,3059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3059,1,3,0)
 ;;=3^Breast Inflammatory Disorders
 ;;^UTILITY(U,$J,358.3,3059,1,4,0)
 ;;=4^N61.
 ;;^UTILITY(U,$J,358.3,3059,2)
 ;;=^5015789
 ;;^UTILITY(U,$J,358.3,3060,0)
 ;;=N63.^^28^247^14
 ;;^UTILITY(U,$J,358.3,3060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3060,1,3,0)
 ;;=3^Breast Lump,Unspec
